LifeStance Health Group I... (LFST)

NASDAQ: LFST · Real-Time Price · USD

6.59

0.02 (0.30%)

At close: May 01, 2025, 3:15 PM

0.30% (1D)

Bid	6.58
Market Cap	2.56B
Revenue (ttm)	1.25B
Net Income (ttm)	-57.44M
EPS (ttm)	-0.15
PE Ratio (ttm)	-43.93
Forward PE	n/a
Analyst	Buy

Ask	6.59
Volume	532,962
Avg. Volume (20D)	1,784,752
Open	6.57
Previous Close	6.57
Day's Range	6.45 - 6.59
52-Week Range	4.64 - 8.61
Beta	1.30

About LFST

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and p...

[Read more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Jun 10, 2021

Employees 10,218

Stock Exchange NASDAQ

Ticker Symbol LFST

Website https://www.lifestance.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for LFST stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 21.40% from the latest price.

Stock Forecasts

Next Earnings Release

LifeStance Health Group Inc. is scheduled to release its earnings on May 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

+8.09%

LifeStance Health Group shares are trading higher ... Unlock content with Pro Subscription

5 months ago

+7.71%

LifeStance Health shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.

News

1 day ago · zacks.com

LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago · seekingalpha.com

LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion

I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and ...

3 weeks ago · zacks.com

LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?

LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

1 month ago · zacks.com

LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

2 months ago · seekingalpha.com

LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conferenc...

2 months ago · zacks.com

LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates

LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.